81255 HEXA (hexosaminidase A [alpha polypeptide]) (eg, Tay-Sachs disease) gene analysis, common variants (eg, 1278insTATC, 1421+1G>C, G269S)

Name of the Procedure:

HEXA (hexosaminidase A [alpha polypeptide]) Gene Analysis, Common Variants (e.g., 1278insTATC, 1421+1G>C, G269S)

Summary

The HEXA gene analysis tests for specific genetic variants linked to Tay-Sachs disease, a hereditary disorder affecting nerve cells. This procedure involves examining the HECA gene to identify mutations that can cause the disease.

Purpose

The procedure aims to diagnose Tay-Sachs disease by identifying mutations in the HEXA gene. Early detection allows for better management of the disease and informed family planning decisions.

Indications

• Family history of Tay-Sachs disease
• Symptoms suggestive of Tay-Sachs, such as muscle weakness or developmental delays.
• Preconception and prenatal testing for at-risk couples.

Preparation

• No special preparations are usually required, but consult your healthcare provider.
• Blood or saliva sample collection may be involved; follow any specific instructions provided by your healthcare team.

Procedure Description

1. A blood or saliva sample is collected from the patient.
2. The genetic material is extracted from the sample.
3. Laboratory analysis is performed to detect the presence of common HEXA gene variants.
4. Results are interpreted by a genetic specialist.

Duration

The sample collection takes only a few minutes. Results can typically be available within a few weeks.

Setting

The sample collection is generally performed at a hospital, outpatient clinic, or specialized genetic testing facility.

Personnel

• Geneticist or genetic counselor
• Nurse or phlebotomist for sample collection
• Laboratory technicians

Risks and Complications

• Minimal risks associated with blood draw (e.g., slight pain, bruising).
• Emotional impact of test results.

Benefits

• Accurate diagnosis of Tay-Sachs disease.
• Informed medical care and family planning.
• Understanding carrier status to inform reproductive choices.

Recovery

• No physical recovery needed.
• Emotional support or genetic counseling may be beneficial following the results.

Alternatives

• Prenatal diagnostic testing (like amniocentesis) for at-risk pregnancies.
• Preimplantation genetic diagnosis (PGD) during IVF for at-risk couples.
• Each alternative has its own set of risks and benefits which should be discussed with a healthcare provider.

Patient Experience

Patients will experience minimal discomfort during the sample collection. The emotional impact varies; genetic counseling can help manage emotions associated with the results.